Umezawa, Y., Torisu‐Itakura, H., Morisaki, Y., ElMaraghy, H., Nakajo, K., Akashi, N., & Saeki, H. (2018). Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: Impact of treatment withdrawal and retreatment of ixekizumab. J Eur Acad Dermatol Venereol.

Umezawa, Y., H. Torisu‐Itakura, Y. Morisaki, H. ElMaraghy, K. Nakajo, N. Akashi, e H. Saeki. "Long‐term Efficacy and Safety Results From an Open‐label Phase III Study (UNCOVER‐J) in Japanese Plaque Psoriasis Patients: Impact of Treatment Withdrawal and Retreatment of Ixekizumab." J Eur Acad Dermatol Venereol 2018.

Umezawa, Y., et al. "Long‐term Efficacy and Safety Results From an Open‐label Phase III Study (UNCOVER‐J) in Japanese Plaque Psoriasis Patients: Impact of Treatment Withdrawal and Retreatment of Ixekizumab." J Eur Acad Dermatol Venereol 2018.